Cystic fibrosis gene modifier SLC26A9 modulates airway response to CFTR-directed therapeutics.
| Image |  |
|---|---|
| Description | scientific article published on October 2016 |
| Author/s | |
| Publication date | October 1, 2016 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |